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  37 
Abstract  38 
Short-term very low energy diets (VLED) are used in clinical practice prior to bariatric surgery, 39 
however, regimens vary and outcomes for a short intervention are unclear. We examined the effect 40 
of two VLEDs; a food-based diet (FD) and meal replacement plan (MRP) (LighterLife) over two weeks 41 
in a randomised controlled trial (RCT).  We collected clinical and anthropometric data, fasting blood 42 
samples, and dietary evaluation questionnaires. Surgeons took liver biopsies and made a visual 43 
assessment of the liver. We enrolled 60 participants and 54 completed (FD n=26, MRP n=28). 44 
Baseline demographic features, reported energy intake, dietary evaluation and liver histology were 45 
comparable between groups. Both diets induced significant weight loss. Perceived difficulty of 46 
surgery correlated significantly with the degree of steatosis on histology.  Circulating inflammatory 47 
mediators: CRP, Fetuin-A and IL6 reduced pre to post diet.  Diets achieved comparable weight loss 48 
and reduction in inflammatory biomarkers, perceived operative difficulty, and patient evaluation.  49 
NAFLD histology assessments post-diet were also not significantly different between diets. Results 50 
indicate effectiveness of short term very low energy diets and energy restriction irrespective of 51 
macronutrient composition although small sample size precluded detection of subtle differences 52 
between interventions.   53 
Keywords 54 
VLED, preoperative, bariatric, NAFLD, energy restriction   55 
Introduction 56 
Ectopic lipid accumulation is a common factor underlying non-alcoholic fatty liver disease (NAFLD), 57 
insulin resistance and Type 2 diabetes (DM) (1).  Metabolic dysfunction is linked  to pro-58 
inflammatory mediators such as Interleukin-6 (IL6), Fetuin-A and C-reactive protein (CRP), which also 59 
contribute to progression to inflammatory non-alcoholic steatohepatitis (2-4). 60 
An energy restricted diet is used prior to bariatric surgery to facilitate the laparoscopic approach to 61 
surgery via a reduction in liver size and improved liver flexibility, by reducing stores of lipid, enabling 62 
access to the upper stomach and oesophagus (5).  In practice, this is achieved with the use of a 63 
short-term pre-operative very low energy diet (VLED), or “liver reducing” diet. Our survey of current 64 
practice in 2013 found significant variability in form, duration and application of the pre-operative 65 
diet used (6).  66 
Although weight loss via a VLED is associated with reversal of the obesity related complications due 67 
to the reduction of ectopic lipid deposits (7), there is limited evidence for the effects of the different 68 
pre-surgery VLEDs on outcomes related to liver histology, inflammatory markers and their 69 
effectiveness related to perceived operative difficulty.   70 
We therefore examined the outcomes of two commonly used VLED regimens in severely obese 71 
adults prior to undergoing bariatric surgery. Our primary outcome was liver histology post-diet, with 72 
secondary outcomes including weight loss achieved, circulating inflammatory markers pre to post 73 
diet, and peri-operative visual assessment of the liver for perceived difficulty of surgery.  We also 74 
asked participants to evaluate the diets.   75 
Materials and Methods  76 
Study design 77 
The study was registered http://www.isrctn.com/, registration number: ISRCTN65605485. 78 
We conducted the RCT between May 2012 and June 2014.  Patients were eligible if they had a body 79 
mass index (BMI) >40kgm2 and acceptance onto the bariatric surgical programme at Derby Hospitals 80 
NHS Foundation Trust following discussion at the bariatric MDT.  Participant exclusion criteria 81 
included; age <18years, secondary NAFLD, Type 2 diabetes treated by medication other than 82 
Biguanides, excess alcohol intake, pregnancy, and exclusions linked to application of a restrictive 83 
dietary regime.   84 
Participants were randomly allocated to receive 800kcal/d VLED for two weeks pre-operatively, 85 
either Derby Teaching Hospitals NHS Foundation Trust standard pre-bariatric surgery food-based 86 
diet (FD) or a Meal replacement plan diet using LighterLife nutritional supplements (MRP).  Block 87 
randomisation was used with matched pairs, for gender and diabetes status.  The participants, and 88 
study team who supplied the dietary information to participants, were not blinded to intervention.   89 
Sampling and data collection 90 
Clinical and anthropometric data were collected during visits and from patients’ notes.  A pre-91 
intervention fasting blood test, weight and height, were taken at the time of the standard pre-92 
operative appointment. On completion of the diet participants completed a short qualitative 93 
evaluation. Participants were weighed post-diet on the morning of their bariatric surgery.  When the 94 
participant was cannulated for anaesthesia a further fasting blood sample was taken.  Intra-95 
operatively a liver biopsy was taken and the surgeon completed a visual assessment of perceived 96 
operative difficulty. 97 
Outcome measures 98 
Primary outcome was histological assessment of a liver biopsy performed at the time of bariatric 99 
surgery (post-diet), secondary outcomes were change in total body weight (pre to post diet), 100 
circulating inflammatory markers (pre to post-diet), peri-operative visual assessment of the liver for 101 
perceived difficulty of surgery and evaluation of dietary approach (post-diet).  102 
Sample size 103 
The sample size was based on an estimation of the difference in liver lipid after following FD or MRP.  104 
For 80% power (at p=0.05) 98 participants would need to be randomised (49 to each arm) to see a 105 
statistically significant difference in the level of steatosis (Instat Graph Pad V2.0 software).  106 
Statistical methods 107 
The data were analysed with IBM SPSS Statistics for WINDOWS version 22 (IBM Corporation).  Two-108 
tailed non-parametric statistical tests were used; Wilcoxon signed rank test, Spearman’s Rho, Mann–109 
Whitney U test, and Kendall’s Tau C Test.  Threshold of significance was defined at P<0·05.  110 
Bonferroni correction for multiple comparisons was carried out where stated.  111 
Further details of methods and data collection are in Supplementary data. 112 
Results  113 
196 potential participants were screened for eligibility over a 25 months period of recruitment. 105 114 
verbally consented to the study, 60 completed informed consent, were randomised and started the 115 
trial, and 54 completed.  Six participants did not complete the study; five due to operations being 116 
cancelled and one patient was started on insulin.  One adverse event, and one serious adverse 117 
event, were reported but were not deemed to be related to the intervention.   118 
Baseline data (Table 1) 119 
Participants’ BMI ranged from 41.5-66.8kg/m2, with a median of 50.7kg/m2.  81.5% of participants 120 
were female, which is consistent with the national average for patients undergoing bariatric surgery.  121 
Age ranged from 24 to 65 years, with median 45.  There was no significant difference between diet 122 
groups demographically or anthropometrically (age P=0.245, BMI P=0.691, gender P=0.568, DM 123 
status P=0.860).   124 
Liver tissue histology (Table 2) 125 
Following the intervention, 12 of 24 participants in the FD group (50%), and 18 of 28 participants in 126 
the MRP group (64%) had histological evidence of steatosis, which were not significantly different.  127 
Three of 24 participants in the FD group (12.5%) and four of 28 participants in the MRP group 128 
(14.3%) showed evidence of moderate or severe steatosis (steatosis grade 2-3).  37% of participants 129 
in the FD group, and 39% of participants in the MRP group, showed evidence of significant portal or 130 
periportal fibrosis; but the difference between groups was not statistically significant. No significant 131 
difference was found between diet groups for steatosis grade (P=0.349), liver cell injury (P=0.567), 132 
portal inflammation (P=0.611), lobular inflammation (P=0.455), or fibrosis stage (P=0.605).   133 
Weight change and self-reported intake (Table 1) 134 
Median total body weight loss was 3.6% in the FD group, and 3.4% in the MRP group.  Results were 135 
not significantly different between diet groups, for body weight loss or percentage weight loss 136 
(P=0.494 and P=0.993 respectively). 137 
Median energy intakes (kcal/d) were not statistically different between diet groups (P=0.311).  138 
Macronutrient energy intake (% total energy intake) differed between the two diets, with protein, 139 
fat and carbohydrate intakes being significantly different between groups (P<0.001 Mann-Whitney 140 
U-Test Bonferroni correction α error probability threshold 0.016).  Fluid intake recommendations 141 
were a minimum of 2L/d, with median reported intakes of 2.2L/d FD, and 2.5L/d MRP.   142 
Surgeons’ assessment  143 
In 22 of the 54 cases, a surgeon completed a visual assessment of 1) access to the gastro-144 
oesophageal junction, 2) liver volume and 3) liver rigidity.  Increasing perceived difficulty was 145 
associated with higher percentages of steatosis (as assessed histologically).  There was a correlation 146 
between visual assessment by the surgeons and the three assessment categories (above).  There 147 
was no significant difference between diets for the three visual analogue assessments; gastric access 148 
(P=0.513), liver volume (P=0.891), liver rigidity (P=0.702).  149 
Blood results 150 
Concentrations of CRP and Fetuin-A reduced significantly after both diets. IL6 reduction was not 151 
significant. 152 
Dietary evaluation 153 
Participants’ self-reported evaluation showed overall satisfaction with the diets was 92% and 85% 154 
satisfied or very satisfied.  82% in the FD group and 93% on the MRP reported that they found the 155 
diet easy to follow.  19% in the FD and 15% in the MRP reported always feeling hunger, whereas 8% 156 
and 11% respectively never felt hungry.  There were no significant differences between evaluation 157 
responses for satisfaction, ease of use or hunger frequency between diets.   158 
Further results in Supplementary data. 159 
Discussion 160 
This RCT examined two energy restrictive dietary regimens aiming for 800kcal/d for a period of two 161 
weeks prior to bariatric surgery. We found that both dietary approaches achieved equivalent and 162 
significant outcomes.  In the two week period of intervention, patients in both groups lost about 163 
3.5% of their total body weight, alongside a reduction in CRP, and Fetuin-A . This reflects an 164 
improvement in obesity related systemic inflammation which requires further work to evaluate 165 
clinical significance.  166 
Macronutrient composition between FD and MRP were significantly different with 52% of total 167 
energy intake from carbohydrate in the FD compared to 38% in MRP group. A previous study has 168 
demonstrated that a reduced carbohydrate diet with moderate energy restriction leads to 169 
significantly more reduction in liver lipid at 48hours than a higher-carbohydrate diet (8).  Our results 170 
demonstrate that when VLED interventions are considered over a period of two weeks, both FD and 171 
MRP were effective irrespective of macronutrient composition.   172 
The main objective of a pre-operative energy restrictive dietary intervention is to improve intra-173 
operative conditions for a laparoscopic surgical procedure.  At the time of surgery, we found a lower 174 
than expected proportion of patients had histological evidence of NAFLD on liver biopsy (9) and 175 
steatosis levels were associated with visual assessment by the surgeons of operative difficulty.  Both 176 
of the pre-operative diets could therefore be reasoned to have enabled surgery, from the 177 
perspective of reducing difficulty of the surgery, due to limiting steatosis.  178 
We also observed reduction in the biomarkers of obesity related systemic inflammatory response. 179 
Fetuin-A is an endogenous ligand for Toll-like receptor-4 through which free fatty acids induce 180 
inflammatory signalling and insulin resistance (10). Patients with severe obesity have markedly 181 
raised Fetuin-A levels.  Markers of systemic inflammation, such as CRP, have been found to be 182 
determinants of risk for development of DM (11).  Although our findings in the RCT are in line with 183 
observations elsewhere, where these markers correlate with measures of obesity, and reduce with 184 
significant weight loss (12-14), the majority of these observations were after longer periods of 185 
energy restriction and greater weight loss. The novelty of our findings were that the observed 186 
reduction in pro-inflammatory cytokines occurred after only two weeks and 3.5% weight loss. 187 
The main limitation to this work is the failure to reach the sample size.  However, the results for 188 
NAFLD are similar to observations elsewhere after an energy restrictive diet when applied in the 189 
severely obese population (15). Further, we were unable to obtain liver biopsies or perform non-190 
invasive estimation of hepatic lipid content using MRI both prior to and after the interventions, 191 
which would have allowed for more conclusive outcome appraisal. Randomisation however appears 192 
to have been effective and no significant differences in demographic or anthropometric profile were 193 
observed between the two groups at baseline. 194 
 195 
In conclusion, our results indicate that energy intake of 715kcal/d for two weeks improves operative 196 
conditions regardless of the macronutrient composition.  Patients were satisfied with VLEDs, which 197 
they also found easy to use. The fatty liver disease we found was in line with similar studies and is 198 
suggestive of an effect of both diets in reducing liver lipid.  Reductions in inflammatory biomarkers 199 
require further investigation. We were unable to demonstrate a difference in either case between 200 
diets, and small sample size may have precluded detection of subtle differences.   201 
 202 
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Tables 255 
 256 
Table 1 Baseline data; Body mass index (BMI), gender, age and diabetes status for the 54 257 
participants that completed the study, separated by dietary intervention.  There were no statistically 258 
different results between diet groups.   259 
Post-diet results for body weight loss (%), self-reported energy intake (kcal/d), and macronutrient 260 
composition of energy intake (kcal/d).  There was no statistically significant difference between 261 
weight loss (P=0.993) or estimated energy intake (P=0.311), however all macronutrient intakes were 262 
significantly different (P<0.001).   263 
All data shown as median (range) unless stated otherwise. 264 
 265 
 FD (n=26) MRP (n=28) 
Gender:  female/ male (n) 22/4 22/6 
No. with Type 2 Diabetes (%)  8 (31) 8 (29) 
Age in years  47 (40) 42 (35) 
BMI kg/m2 51.1 (25.4) 50.1 (21.4) 
 
Weight Loss % 3.6 (3.0) 3.4 (3.7) 
Estimated energy intake kcal/d 715 (558) 715 (275) 
Macronutrient % total 
energy intake 
Carbohydrate 52 (21.5) 38 (7.8) 
Protein 30 (14.7) 37 (7.2) 
Fat 19 (18.8) 25 (14.3) 
  266 
Table 2 267 
Liver histology results from time of surgery (post-diet). 268 
Steatosis results for grade and location, liver cell injury results including lobular and portal 269 
inflammation and fibrosis stage (CRN) for both dietary approaches. 270 
Shown as count (n). 271 
 272 
 
FD 
(n=24)* 
MRP 
(n=28) 
Steatosis grade 
0-3 
0 12 10 
1 9 14 
2 2 2 
3 1 2 
Steatosis 
location  
0-3 
0 22 27 
1 0 0 
2 2 1 
3 0 0 
Liver cell injury 
(ballooning/ 
apoptosis) 
0-3 
0 18 19 
1 6 9 
2 0 0 
Lobular 
inflammation 
0-3 
0 12 19 
1 10 5 
2 0 2 
3 1 2 
Portal 
inflammation  
0-3 
0 4 2 
1 11 15 
2 9 11 
Fibrosis Stage 
(detailed CRN 
definitions) 
None 8 6 
Mild zone 3 perisinusoidal 
(1a) 
0 2 
Portal/periportal (1c) 12 14 
Perisinusoidal and 
portal/periportal (2) 
2 6 
Bridging fibrosis (3) 0 0 
Cirrhosis (4) 2 0 
 273 
* Two participants in the FD group were unable to have liver biopsies taken at the time of surgery. 274 
